510(k) K991083
K991083 is an FDA 510(k) premarket notification submitted by Otsuka Pharmaceutical Co., Ltd. for the device "RLP CHOLESTEROL IMMUNOSEPARATION ASSAY". The FDA issued a decision of Substantially Equivalent on Aug 20, 1999. The device falls under product code CHH (Enzymatic Esterase--Oxidase, Cholesterol), a Class I device regulated under 21 CFR 862.1175. Otsuka Pharmaceutical Co., Ltd. has 5 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Aug 20, 1999
- Date Received
- Mar 31, 1999
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Enzymatic Esterase--Oxidase, Cholesterol
- Device Class
- Class I
- Regulation Number
- 862.1175
- Review Panel
- CH
- Submission Type
- 510(k) Exempt
Need the full FDA record for Otsuka Pharmaceutical Co., Ltd.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.